About Synthematix
Synthematix is a company based in Durham (United States) founded in 2000 was acquired by Symyx Technologies in February 2005. Synthematix offers products and services including ELISA Kits, PCR Kits, Antibodies, and Assay Kits. Synthematix operates in a competitive market with competitors including Insitro, HotSpot Therapeutics, Certara, TOLREMO therapeutics and Inpharmatica, among others.
- Headquarter Durham, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Symyx Technologies
(Feb 23, 2005)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Synthematix
Synthematix offers a comprehensive portfolio of products and services, including ELISA Kits, PCR Kits, Antibodies, and Assay Kits.
Kits for detecting proteins and antibodies in research
Tools for DNA amplification and analysis
Reagents used for immune response studies
Kits for biochemical assays and metabolic analysis
Funding Insights of Synthematix
Detailed funding history for Synthematix
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Synthematix
Synthematix has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Symyx Technologies.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Informatics and automation products for research are offered.
|
Locked | Locked | Locked |
Investor details for Synthematix
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Synthematix
Investment portfolio details for Synthematix
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Synthematix
Detailed financials for Synthematix
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Synthematix Comparisons
Peer comparison for Synthematix
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Synthematix
Synthematix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Insitro, HotSpot Therapeutics, Certara, TOLREMO therapeutics and Inpharmatica, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
An AI-enabled platform is developed for infectious disease treatment.
|
|
| Locked | Locked | Locked |
Developer of a platform for protein function analysis
|
|
| Locked | Locked | Locked |
Provider of a platform for in silico drug discovery and consulting services
|
|
| Locked | Locked | Locked |
Anti-cancer small molecules are developed to target drug resistance pathways.
|
|
| Locked | Locked | Locked |
Developer of predictive informatics based platform for drug discovery
|
|
| Locked | Locked | Locked |
Immune system-based drugs are discovered via biological data analytics.
|
Detailed competitors of Synthematix
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Synthematix
Complete news archive for Synthematix
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Synthematix
Synthematix was founded in 2000.
Synthematix is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Synthematix was founded in 2000 in Durham, United States, focusing on software for organic synthesis in pharmaceutical and biotechnology sectors. ARTHUR, a suite of tools for synthetic chemistry planning, is offered alongside StructureSearch, a substructure search development kit. Deployment services, including installation, training, integration, custom development, and experimental data capture, are provided to support operations.
Synthematix's top competitors include Insitro, HotSpot Therapeutics and Certara.
Synthematix offers ELISA Kits, PCR Kits, Antibodies, and Assay Kits.
Synthematix has 1 investor. Key investors include Symyx Technologies.